Understanding Adenomyosis: Breaking the Myths of This Overlooked Uterine Condition

For years, medical consensus suggested that adenomyosis was primarily a condition affecting women over the age of 40. However, recent advances in imaging are overturning this belief, revealing that a significant number of younger patients also live with this underrecognized disease. Because symptoms are often nonspecific, many women suffer without a clear diagnosis, impacting both their quality of life and their fertility.

What is Adenomyosis?

Adenomyosis occurs when endometrial glands—the tissue that normally lines the uterus—infiltrate the myometrium, which is the muscular wall of the uterus. This ectopic infiltration creates a multifaceted uterine pathology that affects approximately 20% of women in the reproductive age group who seek gynecological care ([MDPI]).

The condition is driven by inflammatory and endocrine alterations. Specifically, research indicates that increased activity of estrogen receptors and progesterone resistance play key roles in the development of the disease ([Endocrinology Advisor]).

Recognizing the Symptoms

One of the greatest challenges in managing adenomyosis is that its presentation varies wildly between patients. In fact, one in three patients remains asymptomatic ([Endocrinology Advisor]). For those who do experience symptoms, they are often debilitating and include:

• Heavy Menstrual Bleeding: This is the most common symptom reported by patients.
• Pelvic Pain and Dysmenorrhea: Severe cramping and general pelvic discomfort.
• Abnormal Uterine Bleeding: Irregular patterns of bleeding between periods.
• Fertility Issues: Impaired fertility is a significant concern for those with the condition ([MDPI]).

The Diagnostic Gap: Why It’s Often Missed

The reported prevalence of adenomyosis ranges from 9% to 62%, but these figures are often inaccurate due to substantial diagnostic barriers ([Endocrinology Advisor]). Historically, a definitive diagnosis was often only made via pathology after a hysterectomy. As Dr. Anna Reinert of Keck Medicine of the University of Southern California notes, relying on post-surgical pathology misses the critical opportunity for early intervention that could improve fertility outcomes.

The Role of Advanced Imaging

Advanced imaging techniques are changing the landscape of diagnosis. These tools are helping clinicians identify adenomyosis in younger women, challenging the outdated notion that the disease only affects older populations ([Endocrinology Advisor]). Better tools for staging the disease are essential for researching treatments that can enhance fertility and alleviate symptoms in younger patient populations.

Fresh Guidance for Treatment

As the medical community works to better identify and stage adenomyosis, new resources are emerging to help providers. On April 3, 2026, Dr. Kimberly Kho, a physician at the University of Hawaii, published a national publication providing a practical roadmap for OB-GYN physicians to better treat the condition ([JABSOM]).

Frequently Asked Questions

Can adenomyosis affect fertility?

Yes. Adenomyosis is associated with impaired fertility and fertility issues, making early diagnosis and intervention critical for those wishing to conceive ([Endocrinology Advisor]).

How common is adenomyosis?

Estimates vary widely due to diagnostic challenges, with reported prevalence ranging from 9% to 62% ([Endocrinology Advisor]). It affects approximately 20% of women in the reproductive age group who seek gynecological care ([MDPI]).

Why is it so hard to diagnose?

Symptoms are often nonspecific and heterogeneous, and many patients are asymptomatic. Diagnostic ambiguities have historically led physicians to overlook the condition in younger women.

As imaging technology improves and new clinical roadmaps are implemented, the goal is to shift adenomyosis from an “overlooked” condition to one that is diagnosed early, allowing for treatments that prioritize both symptom relief and the preservation of fertility.